Matricellular protein thrombospondin-1 in pulmonary hypertension: multiple pathways to disease.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Cardiovascular Research

• Publication date

  2017-07-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1093/cvr/cvx094PMID 28472457PMCID PMC5852507
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Thrombospondin‐1 gene polymorphism is associated with estimated pulmonary artery pressure in patients with sickle cell anemia

  2017cited by this paper
• TSP1–CD47 signaling is upregulated in clinical pulmonary hypertension and contributes to pulmonary arterial vasculopathy and dysfunction

  2017cited by this paper
• Relationship between thrombospondin-1, endostatin, angiopoietin-2, and coronary collateral development in patients with chronic total occlusion

  2016cited by this paper
• Attenuation of Ischemia-Reperfusion Injury and Improvement of Survival in Recipients of Steatotic Rat Livers Using CD47 Monoclonal Antibody

  2016cited by this paper
• CD47 regulates renal tubular epithelial cell self-renewal and proliferation following renal ischemia reperfusion.

  2016cited by this paper
• Physiological mechanisms of pulmonary hypertension.

  2016cited by this paper
• Alteration in cellular turnover and progenitor cell population in lacrimal glands from thrombospondin 1-/- mice, a model of dry eye.

  2016cited by this paper
• The role of circulating thrombospondin-1 in patients with precapillary pulmonary hypertension

  2016influential reference
• Elevated cerebrospinal fluid levels of thrombospondin-1 correlate with adverse clinical outcome in patients with aneurysmal subarachnoid hemorrhage.

  2016cited by this paper
• Physiological levels of thrombospondin-1 decrease NO-dependent vasodilation in coronary microvessels from aged rats.

  2016cited by this paper
• Pre-Clinical Development of a Humanized Anti-CD47 Antibody with Anti-Cancer Therapeutic Potential

  2015cited by this paper
• CD47 Receptor Globally Regulates Metabolic Pathways That Control Resistance to Ionizing Radiation*

  2015cited by this paper
• Association of Plasma Thrombospondin-1 Level with Cardiovascular Disease and Mortality in Hemodialysis Patients.

  2015cited by this paper
• HIF-2α-mediated induction of pulmonary thrombospondin-1 contributes to hypoxia-driven vascular remodelling and vasoconstriction

  2015cited by this paper
• High levels of TSP1+/CD142+ platelet-derived microparticles characterise young patients with high cardiovascular risk and subclinical atherosclerosis

  2015cited by this paper
• Increased sensitivity to kindling in mice lacking TSP1.

  2015cited by this paper
• Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology.

  2014cited by this paper
• Current understanding of the thrombospondin-1 interactome.

  2014cited by this paper
• Thrombospondin-1 activation of signal-regulatory protein-α stimulates reactive oxygen species production and promotes renal ischemia reperfusion injury.

  2014cited by this paper
• Increase in both angiogenic and angiostatic mediators in patients with idiopathic pulmonary fibrosis.

  2014cited by this paper
• Thrombospondin-1 and CD47 signaling regulate healing of thermal injury in mice

  2014influential reference
• Cardiac CD47 Drives Left Ventricular Heart Failure Through Ca2+‐CaMKII‐Regulated Induction of HDAC3

  2014cited by this paper
• [Relevant issues in the pathology and pathobiology of pulmonary hypertension].

  2014cited by this paper
• Rho-kinase inhibitor prevents bleomycin-induced injury in neonatal rats independent of effects on lung inflammation.

  2013cited by this paper
• Thrombospondin-1 triggers macrophage IL-10 production and promotes resolution of experimental lung injury

  2013cited by this paper
• Relevant issues in the pathology and pathobiology of pulmonary hypertension.

  2013cited by this paper
• Age-Associated Induction of Cell Membrane CD47 Limits Basal and Temperature-Induced Changes in Cutaneous Blood Flow

  2013cited by this paper
• Cellular, Pharmacological, and Biophysical Evaluation of Explanted Lungs from a Patient with Sickle Cell Disease and Severe Pulmonary Arterial Hypertension

  2013influential reference
• Nitric oxide: Orchestrator of endothelium-dependent responses

  2012cited by this paper
• Investigation of thrombospondin-1 and transforming growth factor-β expression in the heart of aging mice.

  2012cited by this paper
• Activated CD47 promotes pulmonary arterial hypertension through targeting caveolin-1.

  2012influential reference
• Thrombospondin-1 Regulates Blood Flow via CD47 Receptor–Mediated Activation of NADPH Oxidase 1

  2012cited by this paper
• Suppression of thrombospondin-1 expression during uveal melanoma progression and its potential therapeutic utility.

  2012cited by this paper
• Activated CD47 regulates multiple vascular and stress responses: implications for acute kidney injury and its management.

  2012cited by this paper
• HIF2α acts as an mTORC1 activator through the amino acid carrier SLC7A5.

  2012cited by this paper
• Peroxisome proliferator-activated receptor gamma (PPARγ) regulates thrombospondin-1 and Nox4 expression in hypoxia-induced human pulmonary artery smooth muscle cell proliferation

  2012cited by this paper
• Loss-of-function thrombospondin-1 mutations in familial pulmonary hypertension.

  2012cited by this paper
• Plasma thrombospondin‐1 is increased during acute sickle cell vaso‐occlusive events and associated with acute chest syndrome, hydroxyurea therapy, and lower hemolytic rates

  2012cited by this paper
• Thrombospondin-1 inhibition of vascular smooth muscle cell responses occurs via modulation of both cAMP and cGMP.

  2011cited by this paper
• Thrombospondin-1 Is a Plasmatic Marker of Peripheral Arterial Disease That Modulates Endothelial Progenitor Cell Angiogenic Properties

  2011influential reference
• Heparan Sulfate Modification of the Transmembrane Receptor CD47 Is Necessary for Inhibition of T Cell Receptor Signaling by Thrombospondin-1*

  2011influential reference
• Ocular immune privilege sites.

  2011cited by this paper
• The thrombospondins.

  2011cited by this paper
• Clinical significance of serum levels of sCD36 in patients with systemic sclerosis: preliminary data.

  2011cited by this paper
• Age-dependent regulation of skeletal muscle mitochondria by the thrombospondin-1 receptor CD47.

  2011cited by this paper
• Endogenous Thrombospondin 1 Protects the Pressure-Overloaded Myocardium by Modulating Fibroblast Phenotype and Matrix Metabolism

  2011cited by this paper
• Thrombospondin-1 Inhibits VEGF Receptor-2 Signaling by Disrupting Its Association with CD47*

  2010cited by this paper
• Thrombospondin-1 null mice are resistant to hypoxia-induced pulmonary hypertension

  2010cited by this paper
• Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxation.

  2010influential reference
• Thrombospondin‐1 is an inhibitor of pharmacological activation of soluble guanylate cyclase

  2010cited by this paper
• Signal regulatory protein alpha (SIRPalpha)/CD47 interaction and function.

  2009cited by this paper
• Thrombospondin-1 and CD47 regulate blood pressure and cardiac responses to vasoactive stress.

  2009cited by this paper
• Differential Interactions of Thrombospondin-1, -2, and -4 with CD47 and Effects on cGMP Signaling and Ischemic Injury Responses*

  2009influential reference
• Myoendothelial coupling in the mesenteric arterial bed; segmental differences and interplay between nitric oxide and endothelin‐1

  2009cited by this paper
• Functions and molecular mechanisms of the CD47-SIRPalpha signalling pathway.

  2009cited by this paper
• Matricellular proteins: an overview

  2009cited by this paper
• NADPH oxidases and reactive oxygen species at different stages of chronic hypoxia-induced pulmonary hypertension in newborn piglets.

  2009cited by this paper
• CD47: a new target in cardiovascular therapy.

  2008cited by this paper
• Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling.

  2008cited by this paper
• Thrombospondin 1 promotes tumor macrophage recruitment and enhances tumor cell cytotoxicity of differentiated U937 cells.

  2008cited by this paper
• Extracellular matrix retention of thrombospondin 1 is controlled by its conserved C-terminal region

  2008influential reference
• Endothelial cell apoptosis in chronically obstructed and reperfused pulmonary artery

  2008influential reference
• Treatment of liver ischemia-reperfusion injury by limiting thrombospondin-1/CD47 signaling.

  2008cited by this paper
• Role of the TGF-beta/Alk5 signaling pathway in monocrotaline-induced pulmonary hypertension.

  2008cited by this paper
• Cyclic stretch affects pulmonary endothelial cell control of pulmonary smooth muscle cell growth.

  2008cited by this paper
• Blockade of Thrombospondin-1-CD47 Interactions Prevents Necrosis of Full Thickness Skin Grafts

  2008cited by this paper
• High serum levels of thrombospondin-1 in patients with idiopathic interstitial pneumonia.

  2008cited by this paper
• Gene Silencing of CD47 and Antibody Ligation of Thrombospondin-1 Enhance Ischemic Tissue Survival in a Porcine Model: Implications for Human Disease

  2008cited by this paper
• Thrombospondin-1 limits ischemic tissue survival by inhibiting nitric oxide-mediated vascular smooth muscle relaxation.

  2007cited by this paper
• Interactions between CD47 and Thrombospondin Reduce Inflammation

  2007cited by this paper
• Interactions between CD47 and Thrombospondin Reduce Inflammation1

  2007cited by this paper
• Blocking Thrombospondin-1/CD47 Signaling Alleviates Deleterious Effects of Aging on Tissue Responses to Ischemia

  2007influential reference
• Thrombospondin-1 Inhibits Nitric Oxide Signaling via CD36 by Inhibiting Myristic Acid Uptake*

  2007cited by this paper
• Increasing Survival of Ischemic Tissue by Targeting CD47

  2007cited by this paper
• Thrombospondin/CD47 Interaction: A Pathway to Generate Regulatory T Cells from Human CD4+CD25− T Cells in Response to Inflammation1

  2006cited by this paper
• Skin Graft Vascularization Involves Precisely Regulated Regression and Replacement of Endothelial Cells through Both Angiogenesis and Vasculogenesis

  2006cited by this paper
• Hypoxic pulmonary hypertension: role of superoxide and NADPH oxidase (gp91phox).

  2006cited by this paper
• The structures of the thrombospondin-1 N-terminal domain and its complex with a synthetic pentameric heparin.

  2006cited by this paper
• Shear stress modulates the expression of thrombospondin-1 and CD36 in endothelial cells in vitro and during shear stress-induced angiogenesis in vivo.

  2006cited by this paper
• CD47 Is Necessary for Inhibition of Nitric Oxide-stimulated Vascular Cell Responses by Thrombospondin-1*

  2006cited by this paper
• Thrombospondin-1 antagonizes nitric oxide-stimulated vascular smooth muscle cell responses.

  2006cited by this paper
• Critical overexpression of thrombospondin 1 in chronic leg ischaemia

  2005cited by this paper
• Shear Stress Induced Release of Von Willebrand Factor and Thrombospondin-1 in Uvec Extracellular Matrix Enhances Breast Tumour Cell Adhesion

  2005cited by this paper
• Expression profiling of laser-microdissected intrapulmonary arteries in hypoxia-induced pulmonary hypertension

  2005cited by this paper
• Identification of thrombospondin 1 (TSP-1) as a novel mediator of cell injury in kidney ischemia.

  2005cited by this paper
• Novel integrin antagonists derived from thrombospondins.

  2005cited by this paper
• Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis.

  2005cited by this paper
• Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner.

  2005cited by this paper
• Nitric oxide regulates angiogenesis through a functional switch involving thrombospondin-1.

  2005cited by this paper
• Binding and displacement of vascular endothelial growth factor (VEGF) by thrombospondin: Effect on human microvascular endothelial cell proliferation and angiogenesis

  2004cited by this paper
• Structure of a thrombospondin C‐terminal fragment reveals a novel calcium core in the type 3 repeats

  2004influential reference
• Upregulation of NAD(P)H oxidase 1 in hypoxia activates hypoxia-inducible factor 1 via increase in reactive oxygen species.

  2004cited by this paper
• The N-terminus of thrombospondin: the domain stands apart.

  2004cited by this paper
• Identification of Novel β1 Integrin Binding Sites in the Type 1 and Type 2 Repeats of Thrombospondin-1*

  2004cited by this paper
• Hypoxic inducible factor 1α, extracellular signal-regulated kinase, and p53 are regulated by distinct threshold concentrations of nitric oxide

  2004cited by this paper
• Role of Thrombospondin-1 in Control of von Willebrand Factor Multimer Size in Mice*

  2004cited by this paper
• The thrombospondins.

  2004cited by this paper
• &agr;4&bgr;1 Integrin Mediates Selective Endothelial Cell Responses to Thrombospondins 1 and 2 In Vitro and Modulates Angiogenesis In Vivo

  2004cited by this paper
• Thrombospondin‐1 mediates platelet adhesion at high shear via glycoprotein Ib (GPIb): an alternative/backup mechanism to von Willebrand factor

  2003cited by this paper
• Involvement of a CD47-dependent pathway in platelet adhesion on inflamed vascular endothelium under flow.

  2003cited by this paper

• The Adipokine Hypothesis of Heart Failure With a Preserved Ejection Fraction

  2025cites this paper
• Trophoblast cell response to periodontal pathogens unveils oxidative stress networks between periodontitis and pre-eclampsia: Mendelian randomization, transcriptomic analysis, and cellular experimental validation

  2025cites this paper
• Design and discovery of novel cyclic peptides as TSP1-CD36 interaction inhibitors for intestinal fibrosis treatment.

  2025cites this paper
• Circulating Thrombospondin-1 and Endothelin-1 Levels Tend to Decline with Increasing Obesity Severity in Women: Evidence from a Pilot, Cross-Sectional Study

  2025cites this paper
• If Plan A Does Not Work: The CD47 Ectodomain as a Target for Immune Tolerance

  2025cites this paper
• The dual role of thrombospondin-1 in inflammatory regulation during acute respiratory distress syndrome: a mini-review

  2025cites this paper
• Diagnostic and prognostic utility of plasma thrombospondin-1 levels in traumatic brain injury

  2024cites this paper
• Higher expression of TSR2 aggravating hypertension via the PPAR signaling pathway

  2024cites this paper
• Shear Stress Markedly Alters the Proteomic Response to Hypoxia in Human Pulmonary Endothelial Cells.

  2023cites this paper
• Role of thrombospondin-1 in high-salt–induced mesenteric artery endothelial impairment in rats

  2023cites this paper
• Roles of TSP1-CD47 signaling pathway in senescence of endothelial cells: cell cycle, inflammation and metabolism

  2023cites this paper
• The Vasculature in Pulmonary Fibrosis

  2022cites this paper
• Biomarkers in Cardiorenal Syndrome and Potential Insights Into Novel Therapeutics

  2022cites this paper
• A TMT-based shotgun proteomics uncovers overexpression of thrombospondin 1 as a contributor in pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome

  2022cites this paper
• Upregulated TSP1 and CD47 expression in the lung in nitrofen‐induced congenital diaphragmatic hernia

  2022cites this paper
• SPARC, a Novel Regulator of Vascular Cell Function in Pulmonary Hypertension

  2022cites this paper
• A Novel Protective Role for Matrix Metalloproteinase-8 in the Pulmonary Vasculature.

  2021cites this paper
• CD47 as a potential biomarker for the early diagnosis of severe COVID-19

  2021influential citation
• Thrombospondin-1 CD47 Signalling: From Mechanisms to Medicine

  2021cites this paper
• CD47 and thrombospondin-1 regulation of mitochondria, metabolism, and diabetes.

  2021cites this paper
• The trypsin inhibitor-like domain is required for a serine protease inhibitor of Haemonchus contortus to inhibit host coagulation.

  2021cites this paper
• A Potential Role of the CD47/SIRPalpha Axis in COVID-19 Pathogenesis

  2021cites this paper
• CD47 (Cluster of Differentiation 47).

  2021cites this paper
• Low Dose Hyperoxia Primes Airways for Fibrosis in Mice after Influenza A Infection

  2020cites this paper
• Myeloid-Derived TSP1 (Thrombospondin-1) Contributes to Abdominal Aortic Aneurysm Through Suppressing Tissue Inhibitor of Metalloproteinases-1

  2020cites this paper
• Thrombospondin-1/CD47 signaling modulates transmembrane cation conductance, survival, and deformability of human red blood cells

  2020cites this paper
• Lamprey PHB2 maintains mitochondrial stability by tanslocation to the mitochondria under oxidative stress

  2020cites this paper
• Biological Pathways of Long-Term Visit-to-Visit Blood Pressure Variability in the American Population: Cardiovascular Health Study and Women’s Health Initiatives

  2020influential citation
• Is CD47 a potentially promising therapeutic target in cardiovascular diseases? - Role of CD47 in cardiovascular diseases.

  2020cites this paper
• Vascular TSP1-CD47 signaling promotes sickle cell-associated arterial vasculopathy and pulmonary hypertension in mice.

  2019cites this paper
• Vascular TSP1-CD47 Signaling Promotes Sickle Cell-Associated Arterial Vasculopathy 1 and Pulmonary Hypertension in Mice 2 Promotes Pulmonary Hypertension in

  2019cites this paper
• Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells

  2019cites this paper
• Gene mutations associated with thrombosis detected by whole‐exome sequencing in paroxysmal nocturnal hemoglobinuria

  2019cites this paper
• Thrombospondin 1 Is Increased in the Aorta and Plasma of Patients With Acute Aortic Dissection.

  2019cites this paper
• More than a syllable in fib-ROS-is: The role of ROS on the fibrotic extracellular matrix and on cellular contacts.

  2018cites this paper
• Caveolin-1: a mediator of Glioblastoma cell invasion and an independent negative biomarker of Glioblastoma patient survival

  2018cites this paper
• Pulmonary immunity and extracellular matrix interactions.

  2018cites this paper
• Regulation of Cellular Redox Signaling by Matricellular Proteins in Vascular Biology, Immunology, and Cancer

  2017cites this paper
• Hypoxia and Redox Signaling on Extracellular Matrix Remodeling: From Mechanisms to Pathological Implications

  2017cites this paper